Halozyme Therapeutics competitorsClear all
Partner Therapeutics's top competitors include Verastem Oncology and Agenus.
 Partner Therapeutics Partner Therapeutics is developing and commercializing cancer medicines and combination therapies. |  Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. |  Agenus Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer. | |
Founding Date | Founding Date 2017 | Founding Date 2010 | Founding Date 1994 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Lexington, US HQ Boston, US Lynnwood, US | Locations Needham, US HQ Walsrode, DE | Locations Lexington, US HQ Cambridge, GB Berkeley, US New York, US |
Employees | Employees 179 | Employees 4864% decrease | Employees 32812% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 227.7 m | Valuation ($) 403.2 m |
Twitter followers | Twitter followers 143 | Twitter followers 2.6 k | Twitter followers 2.3 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) 15 | Number of tweets (last 30 days) 2 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 3 | Average likes per tweet (last 30 days) 9.2 | Average likes per tweet (last 30 days) 7.5 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank 120997 | Alexa Website Rank N/A | Alexa Website Rank 155568 |
Employee Rating | Employee Rating 4.4 | Employee Rating N/A | Employee Rating 3.3 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $88.5m (FY, 2020) | Revenue (est.) $88.2m (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods $33.7m (FY, 2020) | Cost of goods $2.3m (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit $54.8m (FY, 2020) | Gross profit $85.8m (FY, 2020) |
Net income | Net income N/A | Net income ($67.7m) (FY, 2020) | Net income ($182.9m) (FY, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 60m | Total funding raised $ 170m | Total funding raised $ 171.1m |
For sources of this data, please see the company profile
View company profiles
Verastem Oncology
HQ
Needham, US
Employees
48
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
View companyAgenus
HQ
Lexington, US
Employees
328↑ 12% increase
Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer.
View company